Document Detail

Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
MedLine Citation:
PMID:  22570679     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Hyponatremia is a common problem in patients with advanced cirrhosis. It develops slowly (paralleling the rate of progression of the liver disease) and usually produces no neurological symptoms, although it may exacerbate hepatic encephalopathy. For patients awaiting liver transplantation a low serum sodium level is a strong predictor of pretransplant mortality, independent of the Model for End-stage Liver Disease score (MELD). The pathogenesis of hyponatremia is related to the hemodynamic changes and secondary neurohormonal adaptations that occur in patients with cirrhosis and ascites. The nonosmotic release of arginine vasopressin is the principle cause of the hyponatremia and vasopressin-receptor antagonists are a new class of drugs recently approved for treatment of cirrhotic hyponatremia. In this article we review the safety and efficacy of V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia.
Shahid Habib; Thomas D Boyer
Related Documents :
6148159 - Primary pulmonary hypertension: natural history and the importance of thrombosis.
7255939 - Intrapulmonary gas transport of he and sf6 in healthy subjects and patients with chroni...
19494539 - Fiberoptic bronchoscopy in neonatal and pediatric intensive care units: a 5-year experi...
10225239 - Is streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? a micro...
16236899 - Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases.
9881259 - Ct-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 c...
6766049 - Nutritional benefits of immediate postoperative jejunal feeding of an elemental diet.
12437309 - Do disease management programs for patients with coronary heart disease make a differen...
18481129 - Cpap compliance in patients with obstructive sleep apnea syndrome.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Therapeutic advances in gastroenterology     Volume:  5     ISSN:  1756-2848     ISO Abbreviation:  Therap Adv Gastroenterol     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-09     Completed Date:  2012-07-10     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101478893     Medline TA:  Therap Adv Gastroenterol     Country:  England    
Other Details:
Languages:  eng     Pagination:  189-97     Citation Subset:  -    
Department of Medicine, Section of Gastroenterology and Hepatology, University of Arizona College of Medicine, Tucson, AZ, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis ...
Next Document:  Secondary causes of nonalcoholic fatty liver disease.